Condition: Acute Myeloid Leukemia · Sponsor: AbbVie
Acute Myeloid Leukemia (AML) is a cancer of the blood and bone marrow and is the most common acute leukemia in adults. This study will evaluate how well Venetoclax works to treat AML in adult participants who are ineligible for intensive chemotherapy in Greece. Venetoclax is a drug approved to treat Acute Myeloid Leukemia. All study participants will receive Venetoclax as prescribed by their study doctor in accordance with approved local label. Adult participants with a new diagnosis of AML who are ineligible for intensive chemotherapy will be enrolled. Around 100 participants will be enrolled in the study in approximately 15 sites in Greece. Participants will receive venetoclax tablets to be taken by mouth daily according to the approved local label. The duration of the study is approximately 30 months. There is expected to be no additional burden for participants in this trial. All study visits will occur during routine clinical practice and participants will be followed for 30 months.
This description comes directly from the study's public registry record.
ABBVIE CALL CENTER · 844-663-3742 · abbvieclinicaltrials@abbvie.com
Always discuss trial participation with your own doctor first.
| Olympion General Clinic /ID# 268392 | Pátrai, Achaia, Greece | Active Not Recruiting |
| General Hospital of Athens Gennimatas /ID# 245968 | Athens, Attica, Greece | Active Not Recruiting |
| General Hospital of Athens Laiko /ID# 244338 | Athens, Attica, Greece | Active Not Recruiting |
| University General Hospital Attikon /ID# 248265 | Athens, Attica, Greece | Active Not Recruiting |
| University General Hospital of Heraklion PA.G.N.I /ID# 244337 | Heraklion, Crete, Greece | Completed |
| General University Hospital of Alexandroupolis /ID# 244235 | Alexandroupoli, Greece | Active Not Recruiting |
| General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 244339 | Athens, Greece | Active Not Recruiting |
| General Anti-cancer Hospital Agios Savvas /ID# 244408 | Athens, Greece | Active Not Recruiting |
| General Hospital of Athens Laiko - Hematology Location /ID# 244234 | Athens, Greece | Active Not Recruiting |
| University General Hospital of Ioannina /ID# 244336 | Ioannina, Greece | Active Not Recruiting |
| University General Hospital of Patras /ID# 244335 | RION Patras Achaia, Greece | Completed |
| Papageorgiou General Hospital /ID# 248266 | Thessaloniki, Greece | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05317494